Belimumab in Idiopathic Inflammatory Myositis
Clinical trial NCT02347891 · COMPLETED
Trial details
- NCT number
- NCT02347891
- Sponsor
- Northwell Health
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2020-11-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.